Alexandar Blazevski

370 Victoria Street
Sydney, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Journal: BJU international

Published: August 05, 2024

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Journal: BJU international

Published: October 20, 2023

Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.

Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.

Journal: BJU international

Published: January 03, 2023

Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.

Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.

Journal: BJU international

Published: December 10, 2022

Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.

Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.

Journal: BJU international

Published: December 10, 2022

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.

Journal: European urology focus

Published: February 05, 2022

Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.

Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.

Journal: BMC urology

Published: October 28, 2021

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.

Journal: European urology

Published: April 16, 2021

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: July 02, 2020

Ureteric obstruction secondary to unusual metastasis of prostate cancer.

Ureteric obstruction secondary to unusual metastasis of prostate cancer.

Journal: Urology case reports

Published: March 16, 2020

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.

Journal: BJU international

Published: January 21, 2020

The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.

The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.

Journal: The Journal of urology

Published: December 12, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026